PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.640.06 (1.08%)
5.46 - 5.64
4.95 - 8.28
2.0K / 2.4K (Avg.)
-282.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.14%
Negative revenue growth while VALMT.HE stands at 14.60%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-51.16%
Negative gross profit growth while VALMT.HE is at 13.38%. Joel Greenblatt would examine cost competitiveness or demand decline.
44.74%
Positive EBIT growth while VALMT.HE is negative. John Neff might see a substantial edge in operational management.
44.74%
Positive operating income growth while VALMT.HE is negative. John Neff might view this as a competitive edge in operations.
32.80%
Positive net income growth while VALMT.HE is negative. John Neff might see a big relative performance advantage.
32.80%
Positive EPS growth while VALMT.HE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
32.80%
Positive diluted EPS growth while VALMT.HE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-18.66%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-14.78%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-40.75%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-28.21%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-14.82%
Negative 3Y CAGR while VALMT.HE stands at 19.20%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
13.15%
10Y OCF/share CAGR under 50% of VALMT.HE's 210.31%. Michael Burry would worry about a persistent underperformance in cash creation.
273.87%
5Y OCF/share CAGR 1.25-1.5x VALMT.HE's 210.31%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
59.82%
3Y OCF/share CAGR under 50% of VALMT.HE's 334.55%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
130.92%
Similar net income/share CAGR to VALMT.HE's 119.99%. Walter Schloss would see parallel tailwinds or expansions for both firms.
110.54%
5Y net income/share CAGR similar to VALMT.HE's 119.99%. Walter Schloss might see both on parallel mid-term trajectories.
-23.14%
Negative 3Y CAGR while VALMT.HE is 121.24%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-2.19%
Negative equity/share CAGR over 10 years while VALMT.HE stands at 115.02%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
28.23%
Below 50% of VALMT.HE's 115.02%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
19.89%
3Y equity/share CAGR above 1.5x VALMT.HE's 10.43%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.58%
Firm’s AR is declining while VALMT.HE shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-0.99%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
3.76%
Asset growth at 75-90% of VALMT.HE's 4.30%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
4.90%
50-75% of VALMT.HE's 7.60%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-10.00%
We’re deleveraging while VALMT.HE stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-5.10%
We cut SG&A while VALMT.HE invests at 19.83%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.